Disclaimer: This article was published in 2021 and reflects the information available at that time.
  There are certain medications that appear in notifications to PDL frequently. While some of these medications are considered low risk and have less potential for harm, it is important for pharmacists to remain vigilant when checking all prescriptions. Here are some examples of medications that have recently seen an increase in reports to PDL. Ozempic injections Ozempic™ is a non-insulin injectable used to treat Type 2 diabetes in adults 18 years and above. Since semaglutide induces side effects on initiation, lower doses are required for at least the first four weeks of use….

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Professional Indemnity cover for pharmacy students
21 April 2026
NationalIncident managementRegulatory and compliancePractice support, tips and tools
Learn more
Communication matters
16 April 2026
NationalNSWLeadership and communicationIncident managementPractice support, tips and tools
Learn more
Professional Indemnity Insurance – what hospital pharmacists need to know
1 April 2026
National
Learn more

It's time to renew your PDL membership for the year ahead.

Renew your PDL membership now and take a moment to review your Practice Profile, as updates have been made to our areas of practice. You can log in to the member portal using your email address or mobile number.